PK Study of Ticagrelor in Children Aged less than 24 Months, with Sickle Cell Disease (HESTIA4)

Trial Identifier: D5136C00010
Sponsor: AstraZeneca
NCTID:: NCT03492931
Start Date: March 2018
Primary Completion Date: May 2019
Study Completion Date: May 2019
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Arabic Translation
Dutch Translation
French Translation
Italian Translation
Kiswahili Translation
Spanish Translation
English Translation

Trial Locations

Country Location
Belgium Edegem, Belgium, 2650
Italy Genova, Italy, 16100
Kenya Nairobi, Kenya, 00100
Lebanon Beirut, Lebanon, 11-0236
Lebanon Tripoli, Lebanon, 1434
Spain Madrid, Spain, 28007
United Kingdom London, United Kingdom, SE1 7EH